Skip to main content

Table 1 PRM verified proteins in targeted proteomics analysis

From: Identification of COPA as a potential prognostic biomarker and pharmacological intervention target of cervical cancer by quantitative proteomics and experimental verification

Protein Accession Gene name SCC/H Ratio SCC/H
p value
AC/H
Ratio
AC/H
p value
AC/SCC Ratio AC/SCC
p value
P53621 COPA 2.07 4.00E−03 2.80 2.53E−04 1.35 2.95E−02
Q7Z3K3 POGZ 4.74 1.46E−04 6.43 4.98E−05 1.36 5.30E−02
Q8N2K0 ABHD12 2.86 2.12E−06 3.93 6.60E−03 1.37 1.11E−01
P04275 VWF 0.72 1.30E−01 0.75 2.07E−01 1.04 7.68E−01
Q6YHK3 CD109 1.08 6.71E−01 0.47 1.05E−03 0.44 3.49E−05
P52209 PGD 5.00 1.83E−03 3.00 1.12E−02 0.60 2.74E−02
P27482 CALML3 6.85 4.03E−03 0.93 9.36E−01 0.14 5.31E−05
P02671 FGA 0.35 1.99E−02 0.54 1.06E−01 1.53 2.61E−02
P02679 FGG 0.42 1.23E−02 0.61 8.61E−02 1.45 1.83E−02
P00568 AK1 0.90 5.27E−01 1.23 3.65E−01 1.37 5.33E−02
Q9UIJ7 AK3 0.96 7.95E−01 0.95 8.07E−01 0.99 9.55E−01
P43034 PAFAH1B1 1.31 1.26E−01 1.27 1.12E−01 0.97 7.92E−01
Q14624 ITIH4 0.48 7.14E−05 0.56 1.23E−03 1.16 2.92E−01
P01860 IGHG3 0.46 2.71E−05 0.44 1.32E−04 0.95 7.86E−01
Q9H223 EHD4 1.22 2.67E−01 1.33 1.35E−01 1.09 5.04E−01
P42765 ACAA2 0.97 8.73E−01 1.76 1.26E−01 1.81 1.80E−02
P02649 APOE 0.28 5.01E−06 0.46 6.79E−03 1.64 6.50E−02
Q9BSJ8 ESYT1 1.63 4.62E−04 1.62 7.65E−03 0.99 9.46E−01
O60716 CTNND1 5.21 5.00E−04 3.34 3.27E−04 0.64 1.79E−02